PBSS-San Francisco: Small-Molecule Formulation for Discovery & Early Development
PBSS Small Molecule Formulation for Discovery and Early Development Workshop in Foster City is a specialized event that focuses on the formulation challenges and strategies for small molecule drug development, particularly in early stages of discovery and preclinical development. This workshop brings together experts to discuss best practices, emerging technologies, and key issues that impact the efficacy, stability, and delivery of small molecule drugs.
Date: January 22, 2025
Location: Foster City, CA
Booth: Catalent
JOIN US!
Stop by our booth to learn about the latest advancements in early phase development. Don’t miss out on our featured talk covering a key industry topic – Navigating the Path to Phase 1: Leveraging Developability Assessments for Formulation Success at 3:00 pm.
Complete the form to schedule a meeting with Catalent at the PBSS San Francisco Bay.
WORKSHOP PRESENTATION
Title: Navigating the Path to Phase 1: Leveraging Developability Assessments for Formulation Success
Date: January 22, 2025
Time: 3:00 pm
SPEAKER
Lisa Caralli
Senior Director, Scientific Advisory
Catalent
ABOUT CATALENT
Catalent, Inc. (NYSE: CTLT), is a global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,500 partner development programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply nearly 70 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 17,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated approximately $4.4 billion in revenue in its 2024 fiscal year. For more information, visit www.catalent.com.
